Assessing biosafety using NGS-based tests requires a continuum of skills in molecular biology, biocomputing, virology, and quality systems.
Laurent Lafferrère
Advertisement
Laurent Lafferrère, PhD, is chief operating officer at PathoQuest.
Articles by Laurent Lafferrère
Advertisement
Latest Updated Articles
Challenges When Outsourcing Viral Safety ServicesPublished: May 16th 2021 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
